newsfilter
← Latest News
GlobeNewswire·

ERYTECH Confirms Plans To Submit BLA for Eryaspase in Hypersensitive ALL Patients

ERYTECH Confirms Plans To Submit BLA for Eryaspase in Hypersensitive ALL Patients Meeting with the U.S. FDA clarified steps and requirements for the submission of a Biologics License Application (BLA) for eryaspase for the treatment of ALL patients w